ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced

November 5, 2010

In Brief: FY 1985 Budget Breakdown; Control Gets $64 Million, Construction $6.5; W. VA. $4.5 Maybe

November 9, 1984

Obama Nominates Regina Benjamin For Surgeon General

July 17, 2009

Troubled Roswell Park Cancer Institute Bets On Recruitment To Regain Its Luster.

January 19, 2001

UICC Fellowship, Exchange Programs

July 5, 1985

Also in this 12-page issue: ASCO urges freeze of Medicare payments for chemotherapy at 2004 levels for next two years.

February 20, 2004